Michael A. Durante

Hematology Oncology | Hospital Medicine

Fort Myers, FL 33902

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Whole-genome sequencing of cell-free DNA for assessment of minimal residual disease in high-risk smoldering multiple myeloma.

Whole-genome sequencing of cell-free DNA for assessment of minimal residual disease in high-risk smoldering multiple myeloma.

Journal: HemaSphere

Published: January 13, 2026

Plasma cell identity escape drives resistance to anti-BCMA T-cell-redirecting therapy in multiple myeloma.

Plasma cell identity escape drives resistance to anti-BCMA T-cell-redirecting therapy in multiple myeloma.

Journal: bioRxiv : the preprint server for biology

Published: December 19, 2025

Genomics Define Malignant Transformation in Myeloma Precursor Conditions.

Genomics Define Malignant Transformation in Myeloma Precursor Conditions.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: October 08, 2025

Early Genetic Evolution of Driver Mutations in Uveal Melanoma.

Early Genetic Evolution of Driver Mutations in Uveal Melanoma.

Journal: medRxiv : the preprint server for health sciences

Published: June 30, 2025

Elevated circulating tumor cells reflect high proliferation and genomic complexity in multiple myeloma.

Elevated circulating tumor cells reflect high proliferation and genomic complexity in multiple myeloma.

Journal: HemaSphere

Published: June 21, 2025

Genomic mechanisms of resistance to venetoclax in multiple myeloma with t(11;14)(CCND1;IGH).

Genomic mechanisms of resistance to venetoclax in multiple myeloma with t(11;14)(CCND1;IGH).

Journal: Blood

Published: May 15, 2025

Genomic mechanisms of resistance to venetoclax in multiple myeloma with t(11;14)(CCND1;IGH).

Genomic mechanisms of resistance to venetoclax in multiple myeloma with t(11;14)(CCND1;IGH).

Journal: Blood

Published: May 15, 2025

Early genetic evolution of driver mutations in uveal melanoma.

Early genetic evolution of driver mutations in uveal melanoma.

Journal: Nature communications

Published: January 31, 2025

Timing Genomic Antigen Loss in Multiple Myeloma Treated with T Cell-Redirecting Immunotherapies.

Timing Genomic Antigen Loss in Multiple Myeloma Treated with T Cell-Redirecting Immunotherapies.

Journal: Blood cancer discovery

Published: January 07, 2025

Biallelic antigen escape is a mechanism of resistance to anti-CD38 antibodies in multiple myeloma.

Biallelic antigen escape is a mechanism of resistance to anti-CD38 antibodies in multiple myeloma.

Journal: Blood

Published: December 16, 2024

Mutagenic impact and evolutionary influence of radiotherapy in hematologic malignancies.

Mutagenic impact and evolutionary influence of radiotherapy in hematologic malignancies.

Journal: bioRxiv : the preprint server for biology

Published: November 28, 2024

Mutagenic Impact and Evolutionary Influence of Chemoradiotherapy in Hematologic Malignancies.

Mutagenic Impact and Evolutionary Influence of Chemoradiotherapy in Hematologic Malignancies.

Journal: Blood cancer discovery

Published: November 25, 2024

Showing 1-12 of 41

Last Updated: 09/26/2026